WestEnd Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32K Hold
6
﹤0.01% 175
2026
Q1
$1.76K Hold
6
﹤0.01% 169
2025
Q4
$2.1K Sell
6
-1
-14% -$338 ﹤0.01% 157
2025
Q3
$2.26K Sell
7
-3
-30% -$933 ﹤0.01% 147
2025
Q2
$3.89K Buy
10
+1
+11% +$402 ﹤0.01% 112
2025
Q1
$3.92K Buy
9
+6
+200% +$2.41K ﹤0.01% 111
2024
Q4
$1.11K Hold
3
﹤0.01% 126
2024
Q3
$1.56K Hold
3
﹤0.01% 100
2024
Q2
$1.63K Sell
3
-1
-25% -$529 ﹤0.01% 95
2024
Q1
$2.07K Hold
4
﹤0.01% 86
2023
Q4
$1.89K Buy
4
+1
+33% +$462 ﹤0.01% 89
2023
Q3
$1.31K Buy
+3
New +$1.36K ﹤0.01% 97
2023
Q1
Sell
-3
Closed -$1.43K 90
2022
Q4
$1.54K Hold
3
﹤0.01% 83
2022
Q3
$1K Hold
3
﹤0.01% 107
2022
Q2
$1.45K Buy
+3
New +$1.48K ﹤0.01% 96
2022
Q1
Sell
-2
Closed -$914 109
2021
Q4
$927 Buy
+2
New +$841 ﹤0.01% 114
2021
Q3
Hold
0
115
2021
Q2
Hold
0
111

Other funds holding ELV

WestEnd Advisors's ELV Position: Q2 2026 in Review

WestEnd Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 6 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #175.

WestEnd Advisors first reported a position in ELV in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.92K in Q1 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • WestEnd Advisors held 6 shares of Elevance Health worth $2.32K as of Q2 2026.
  • WestEnd Advisors left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #175 holding.
  • WestEnd Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 16 quarters since.
  • WestEnd Advisors's Elevance Health position peaked at $3.92K in Q1 2025.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.